Immunological characterization of conjugated Haemophilus influenzae type b vaccine failure in infants

Clinical Infectious Diseases

Volumn 32, Issue 12, 2001, Pages 1700-1705

  Breukels, Mijke A ^a   Spanjaard, Lodewijk ^b   Sanders, Lieke A M ^a   Rijkers, Ger T ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN G ANTIBODY; TETANUS TOXOID;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; CHILD; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HAEMOPHILUS INFLUENZAE; HUMAN; IMMUNODIFFUSION; INFANT; MALE; MENINGITIS; PRIORITY JOURNAL; TREATMENT FAILURE; VACCINATION;

ADOLESCENT; ADULT; CHILD; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; MALE; MENINGITIS, HAEMOPHILUS; MIDDLE AGED; POLYSACCHARIDES, BACTERIAL; TREATMENT FAILURE; VACCINES, CONJUGATE;

EID: 0035004062     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/320755     Document Type: Article

References (34)

1. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease
2. Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T
3. Predicted disappearance of Haemophilus influenzae type b meningitis in Netherlands
4. Effect of nationwide vaccination of 3-month-old infants in The Netherlands with conjugate Haemophilus influenzae type b vaccine: High efficacy and lack of herd immunity
5. Latex agglutination, counterimmunoelectrophoresis, and protein A co-agglutination in diagnosis of bacterial meningitis
6. Preparation of human hyperimmune globulin to Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidis
7. Haemophilus influenzae type b
8. Haemophilus influenzae type b capsular polysaccharide vaccine in children: A double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland
9. Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates
10. The 1996 Albert Lasker Medical Research Awards. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b. Impact on public health and implications for other polysaccharide-based vaccines
11. Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines
12. Epidemiology of Haemophilus influenzae type b infections in The Netherlands and elsewhere
13. Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine
14. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine
15. Immunoglobulin deficiency and idiotype expression in children developing Haemophilus influenzae type b disease after vaccination with conjugate vaccine
16. The biology of Haemophilus influenzae type b vaccination failure
17. Haemophilus influenzae type B disease in children vaccinated with type B polysaccharide vaccine
18. Antibody persistence and Haemophilus influenzae type b carriage after infant immunisation with PRP-T
19. High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines
20. Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies
21. Efficacy of human hyperimmune globulin in prevention of Haemophilus influenzae type b disease in infant rats
22. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b
23. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b
24. Serum opsonic activity for Haemophilus influenzae type b in infants immunized with polysaccharide-protein conjugate vaccines
25. Immunity to Haemophilus influenzae type b in young adults: Correlation of bactericidal and opsonizing activity of serum with antibody to polyribosylribitol phosphate and lipooligosaccharide before and after vaccination
26. Host and bacterial factors associated with Haemophilus influenzae type b disease in Minnesota children vaccinated with type b polysaccharide vaccine
27. Prevention of Haemophilus influenzae type b infections in Apache and Navajo children
28. Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentrations in Apache children
29. Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants
30. A defective Vkappa A2 allele in Navajos which may play a role in increased susceptibility to haemophilus influenzae type b disease
31. Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria
32. G2m(23) immunoglobulin allotype and immunity to Haemophilus influenzae type b
33. Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils
34. Human IgG Fc receptors